Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
126.03
-1.64 (-1.28%)
Nov 13, 2024, 4:00 PM EST - Market closed
Ascendis Pharma Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -489.52 | -481.45 | -583.19 | -383.58 | -418.96 | -218.02 | Upgrade
|
| Depreciation & Amortization | 18.1 | 18.43 | 17.51 | 14.95 | 9.45 | 6.69 | Upgrade
|
| Other Amortization | 0.48 | 0.48 | 0.44 | 0.45 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.11 | 0.01 | 0.02 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 7.83 | 7.83 | - | - | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | 20.84 | 18.4 | 17.7 | -12.04 | 9.52 | 8.11 | Upgrade
|
| Stock-Based Compensation | 76.42 | 66.66 | 64.18 | 66.83 | 53.17 | 37.49 | Upgrade
|
| Other Operating Activities | 149.67 | 2.07 | 0.11 | -56.53 | 76.23 | -14.28 | Upgrade
|
| Change in Accounts Receivable | -44.81 | -32.77 | -11.53 | -6.66 | -2 | -2.18 | Upgrade
|
| Change in Inventory | -83.28 | -78.26 | -55.27 | -75.41 | - | - | Upgrade
|
| Change in Accounts Payable | -16.34 | 3.55 | 45.94 | 39.19 | 7.88 | 7.53 | Upgrade
|
| Change in Unearned Revenue | 1.2 | -7.08 | 8.65 | 5.2 | -0.5 | -6.04 | Upgrade
|
| Change in Other Net Operating Assets | 29.42 | 14.77 | -0.26 | -10.05 | -6.36 | 4.77 | Upgrade
|
| Operating Cash Flow | -330.08 | -467.36 | -495.7 | -417.65 | -271.55 | -175.94 | Upgrade
|
| Capital Expenditures | -1.45 | -2.44 | -14.49 | -23.7 | -19.86 | -5.16 | Upgrade
|
| Sale of Property, Plant & Equipment | 1 | 0.05 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | -0.53 | -1.69 | - | Upgrade
|
| Investment in Securities | 37.09 | 288.87 | 66.69 | -86.35 | -274.7 | - | Upgrade
|
| Other Investing Activities | - | - | 9.54 | - | 5.05 | - | Upgrade
|
| Investing Cash Flow | 36.63 | 286.47 | 61.73 | -110.58 | -291.2 | -5.16 | Upgrade
|
| Long-Term Debt Issued | - | 136.26 | 503.28 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -10.44 | -6.36 | -6.43 | -4.77 | -4.04 | Upgrade
|
| Net Debt Issued (Repaid) | 125.3 | 125.82 | 496.93 | -6.43 | -4.77 | -4.04 | Upgrade
|
| Issuance of Common Stock | 29.79 | 10.29 | 5.15 | 379.42 | 607.42 | 497.63 | Upgrade
|
| Repurchase of Common Stock | -1.81 | -1.81 | -105.31 | -21.61 | - | - | Upgrade
|
| Financing Cash Flow | 153.27 | 134.29 | 396.77 | 351.39 | 602.65 | 493.59 | Upgrade
|
| Foreign Exchange Rate Adjustments | 4.65 | -6.01 | 35.69 | 38.59 | -53.49 | 7.75 | Upgrade
|
| Net Cash Flow | -135.53 | -52.6 | -1.5 | -138.25 | -13.59 | 320.24 | Upgrade
|
| Free Cash Flow | -331.53 | -469.8 | -510.19 | -441.35 | -291.41 | -181.1 | Upgrade
|
| Free Cash Flow Margin | -104.38% | -176.14% | -996.97% | -5674.38% | -4191.11% | -1353.98% | Upgrade
|
| Free Cash Flow Per Share | -5.84 | -8.35 | -9.10 | -8.06 | -5.76 | -3.89 | Upgrade
|
| Cash Interest Paid | 15.64 | 15.67 | 9.29 | 1.84 | 1.5 | 0.72 | Upgrade
|
| Cash Income Tax Paid | 6.72 | 4.47 | 0 | -0.15 | -1.1 | 0.28 | Upgrade
|
| Levered Free Cash Flow | -104.13 | -318.3 | -314.37 | -281.9 | -171.19 | -98.28 | Upgrade
|
| Unlevered Free Cash Flow | -20.95 | -290.76 | -295.19 | -279.45 | -169.99 | -97.51 | Upgrade
|
| Change in Net Working Capital | -106.39 | 89.17 | 11.71 | 55.07 | 4.42 | -5.16 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.